Literature DB >> 22589339

eComment. Activated recombinant factor VII in intractable bleeding after cardiac surgery.

Jamil Hajj-Chahine1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22589339      PMCID： PMC3352747          DOI： 10.1093/icvts/ivs121

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN： 1569-9285


× No keyword cloud information.
  4 in total

1.  Successful use of a military haemostatic agent in patients undergoing extracorporeal circulatory assistance and delayed sternal closure.

Authors:  Luigi Muzzi; Giulio Tommasino; Enrico Tucci; Eugenio Neri
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-02-24

2.  Is recombinant activated factor VII useful for intractable bleeding after cardiac surgery?

Authors:  Marios Tanos; Joel Dunning
Journal:  Interact Cardiovasc Thorac Surg       Date:  2006-05-03

3.  A new hemostatic agent: initial life-saving experience with Celox (chitosan) in cardiothoracic surgery.

Authors:  Russell W J Millner; Alan S Lockhart; Helen Bird; Christos Alexiou
Journal:  Ann Thorac Surg       Date:  2009-02       Impact factor: 4.330

4.  Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7).

Authors:  Marie Hacquard; Marion Durand; Thomas Lecompte; Stéphanie Boini; Serge Briançon; Jean-Pierre Carteaux
Journal:  Eur J Cardiothorac Surg       Date:  2011-05-06       Impact factor: 4.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.